Join Now!      Login

Whole Person Wellness Program
 
healthy.net Wellness Model
Skip Navigation Links
 
 
FREE NEWSLETTER
   
   
   
 
Health Centers
Key Services
 
Antioxidants?
Which of the following is an antioxidant?
Vitamin E
Vitamin B
Calcium


 
 

 The Great Prozac Conspiracy 
 
The following is one in an ongoing series of columns entitled What Doctors Don't Tell You by . View all columns in series
After 20 years of these so-called miracle antidepressants, psychiatrists are shocked to discover that drug companies withheld information about the risks of this class of drugs--and with the tacit approval of the drug regulators.

It all started so promisingly, when drugs like Prozac first came on the market in the 1980s. Here at last, we were told, was a new class of antidepressants that would transform the world of psychiatry.

Out would go the old ‘dirty’ psychiatric drugs of the 1950s, and in would come a set of drugs honed by science to target the biochemical core of depression in the brain.

These new drugs had a very scientific-sounding name—‘selective serotonin reuptake inhibitors’—which neatly morphed into the catchy acronym ‘SSRIs’. They are among the most successfully marketed drugs in history, so much so that the brand leader Prozac is almost a synonym for antidepressants, just like Hoover is for vacuum cleaners.

But now, some two decades later, the world of psychiatry has finally discovered it has been largely taken for a ride with SSRIs, by both drug companies and lax regulators.

‘Miracle’ science
In the brain, messages are passed between brain cells (neurones) across a tiny gap called a ‘synapse’. This gap is filled with chemicals, which have the job of controlling the communication between brain cells, transmitting information from one neurone to the other. Hence, these chemicals are called ‘neurotransmitters’. When one neurone communicates with its neighbour, it floods the synapse with a cocktail of neurotransmitters, one of which is serotonin.

By the 1970s, it had been discovered that some prescription drugs can cause depression as a side-effect, a problem traced to low brain levels of serotonin. It was then argued that, if a way could be found to increase serotonin in the brain, it would reduce depression.

It’s already known that the brain naturally conserves neurotransmitters by allowing the transmitting cell to reabsorb them from the synapse (a process that is called reuptake). So, if a way can be found to stop (or inhibit) this reuptake, the synapse would remain constantly bathed in neurotransmitters. But only one neurotransmitter—serotonin—is involved in depression, which means that only serotonin needs to be selectively isolated from the rest of the neurotransmitter cocktail.

So, in the mid-1970s, the pharmaceutical companies set themselves the task of finding a drug that would select out serotonin, and inhibit its reabsorption by the transmitting neurones. Ten years later, the family of SSRIs was created.

The first SSRI appeared in the mid-1980s from the Swedish pharma company Astra. The drug’s chemical name was zimelidine, but it was quickly withdrawn from the market when patients developed Guillain–Barré syndrome (a serious auto-immune condition involving damage to the peripheral nerves). Soon after-wards, a second SSRI, a French drug called indalpine, was also stopped after it was found to damage blood cells.

These straws in the wind didn’t deter other drug companies, however —although the SSRI’s hoped-for lack of side-effects had been intended to be a major part of their sales pitch.

The first SSRI to come to market was fluvoxamine (see box, page 8), but its manufacturer Solvay Pharmaceutical, based in Georgia, lacked marketing clout, making its launch a bit of a damp squib.

It took the marketing power wielded by the giant US (and international) drug company Eli Lilly to collar most of the SSRI public relations when it launched fluoxetine in 1987, under the memorable trade-name Prozac. Newspapers were quick to swallow the company’s sales pitch, with headlines describing Prozac as a “happiness pill”. Even normally cynical journalists described Prozac as a valuable, quick, emotional fix, and a panacea for the stresses of the 20th century.

   CONTINUED    1  2  3  4  5  Next   
 Comments Add your comment 

 About The Author
What Doctors Don’t Tell You is one of the few publications in the world that can justifiably claim to solve people's health problems - and even save lives. Our monthly newsletter gives you the facts you won't......moreWhat Doctors Don't Tell You
 
 From Our Friends
 
 
 
Popular & Related Products
 
Popular & Featured Events
Integrative Healthcare Symposium 2015
     February 19-21, 2015
     New York, NY USA
 
Wellness Inventory Certification Training (Level I)
     February 24-May 26, 2015
     Teleclass, CA USA
 
Additional Calendar Links
 
Stevia Products & Info
 
Dimensions of Wellness
Wellness, Eating, dimension!

Home       Wellness       Health A-Z       Alternative Therapies       Find a Practitioner       Healthy Products       Bookstore       Wellness Inventory
Healthy Kitchen       Healthy Woman       Healthy Man       Healthy Child       Healthy Aging       Wellness Center       Nutrition Center       Fitness Center
Free Newsletter      What Doctor's Don't Tell You      Stevia.com      Discount Lab Tests      First Aid      Global Health Calendar      Privacy Policy     Contact Us
Disclaimer: The information provided on HealthWorld Online is for educational purposes only and IS NOT intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek professional medical advice from your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.
Are you ready to embark on a personal wellness journey with our whole person approach?
Learn More/Subscribe
Are you looking to create or enhance a culture of wellness in your organization?
Learn More
Do you want to become a wellness coach?
Learn More
Free Webinar